BioNTech

recent-pharma-happenings-for-pfizer-biontech-oncoimmune-recursion

Sep 10, 2020

Pfizer-BioNTech COVID-19 vaccine trials; OncoImmune raises $56 M; Recursion Pharma nets $239 M; Breast cancer research updates

Pharma News | COVID-19 News | Cancer News

Jul 14, 2020

Merck, Dewpoint’s HIV Pipeline; Pfizer, BioNTech ‘s COVID-19 Vaccines; Roche’s Tecentriq- Avastin Duo Failure in Ovarian Cancer

pharma-news

Apr 30, 2020

Remdesivir accelerates for COVID-19 recovery; Merck pact with Almac; Pfizer, BioNTech finish dosing in; Taysha Gene Therapies for trials

mRNA

Mar 14, 2019

BioNTech lines up $800M; Deerfield remunerates; Britain’s Smith & Nephew to acquire Osiris

Delveinsight

Jan 12, 2018

Adapsyn signed; Evolus filed; BioNTech signed a deal; Nordisk’s deal

Sep 22, 2016

Sygnis AG and ECACC Collaboration; BioNTech and Genentech Partnership; Partnership between Zydus Cadila and Takeda; Global Agreement between Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper